These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4156595)

  • 21. Tolerance to phenothiazines in schizophrenic patients.
    Malek-Ahmadi P; Chapel JL
    Gen Pharmacol; 1976 Dec; 7(6):377-9. PubMed ID: 14052
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glucuroconjugation in vitro of chloramphenicol in normal rats and in rats pre-treated with phenobarbital].
    Stramentinoli G; Gazzaniga A; Bonanomi L
    Boll Chim Farm; 1974 Oct; 113(10):535-9. PubMed ID: 4447679
    [No Abstract]   [Full Text] [Related]  

  • 23. [Elimination of drugs by residual nephrons].
    Schück O; Grafnetterová J; Mádvorníková H; Prát V
    Vnitr Lek; 1976 Jul; 22(7):654-62. PubMed ID: 988939
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of chloramphenicol on the mother and baby. II. Transfer, absorption, excretion and adverse effects of chloramphenicol in the newborn infant].
    Kunii K
    Jpn J Antibiot; 1970 Aug; 23(4):363-78. PubMed ID: 5312787
    [No Abstract]   [Full Text] [Related]  

  • 25. Complete ultrarapid metabolism of flupentixol in 42 year old patient suffering from chronic schizophrenia.
    Koch HJ; Zellmer H
    Therapie; 2013; 68(2):117-8. PubMed ID: 23773353
    [No Abstract]   [Full Text] [Related]  

  • 26. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 27. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 28. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 29. Chloramphenicol dosage.
    Clark CH
    Mod Vet Pract; 1978 Oct; 59(10):749-54. PubMed ID: 368560
    [No Abstract]   [Full Text] [Related]  

  • 30. Disposition of remoxipride in Chinese schizophrenic patients.
    Lin SK; Chang WH; Chien CP; Lam YW; Jann MW
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):17-20. PubMed ID: 8688992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anesthetic management for schizophrenic patients on chronic phenothiazine therapy (author's transl)].
    Murakawa T; Matsuki A; Oyama T
    Masui; 1977 Oct; 26(10):1154-61. PubMed ID: 21976
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of intravenously injected chloramphenicol in baby pigs.
    Rao VR; Clarenburg R
    Drug Metab Dispos; 1977; 5(3):253-8. PubMed ID: 17523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of thiamphenicol and comparative studies of its urinary and biliary excretion with chloramphenicol in various species.
    Uesugi T; Ikeda M; Hori R; Katayama K; Arita T
    Chem Pharm Bull (Tokyo); 1974 Nov; 22(11):2714-22. PubMed ID: 4468102
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychopharmacological treatment of schizophrenia.
    Lehmann HE
    Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 36. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 37. Auditory signal detection in paranoid and nonparanoid schizophrenics.
    Rappaport M; Hopkins HK; Hall K
    Arch Gen Psychiatry; 1972 Dec; 27(6):747-52. PubMed ID: 4404700
    [No Abstract]   [Full Text] [Related]  

  • 38. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of chloramphenicol in domesticated animals.
    Davis LE; Neff CA; Baggot JD; Powers TE
    Am J Vet Res; 1972 Nov; 33(11):2259-66. PubMed ID: 5081486
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of risperidone in chronic schizophrenic patients.
    Borison RL; Diamond B; Pathiraja A; Meibach RC
    Psychopharmacol Bull; 1994; 30(2):193-7. PubMed ID: 7530379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.